ABEONA THERAPEUTICS INC. Other Comprehensive Income (Loss), Net of Tax
ABEONA THERAPEUTICS INC. (ABEO) reported Other Comprehensive Income (Loss), Net of Tax of -$58.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- ABEONA THERAPEUTICS INC. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$58.00K, a 363.64% decline year-over-year.
- ABEONA THERAPEUTICS INC. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$159.00K.
- ABEONA THERAPEUTICS INC. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $128.00K, a 39.13% increase year-over-year.
- ABEONA THERAPEUTICS INC. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $55.00K, a 10.00% increase year-over-year.
- ABEONA THERAPEUTICS INC. other comprehensive income (loss), net of tax for fiscal 2025 was $130.00K, a 75.68% increase from fiscal 2024.
- ABEONA THERAPEUTICS INC. other comprehensive income (loss), net of tax for fiscal 2024 was $74.00K, a 17.46% increase from fiscal 2023.
- ABEONA THERAPEUTICS INC. other comprehensive income (loss), net of tax for fiscal 2023 was $63.00K.
- ABEONA THERAPEUTICS INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$102.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 9 month as first filed | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$58.00K 10-Q · filed 2026-08-13 | -$217.00K 10-Q · filed 2026-08-13 | -$89.00K derived: sum of 3 quarters · filed 2026-08-13 | -$34.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | -$159.00K 10-Q · filed 2026-05-13 | -$31.00K derived: sum of 2 quarters · filed 2026-05-13 | $24.00K derived: sum of 3 quarters · filed 2026-05-13 | $46.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $183.00K derived: sum of 2 quarters · filed 2026-03-17 | $205.00K derived: sum of 3 quarters · filed 2026-08-13 | $130.00K 10-K · filed 2026-03-17 | ||
| 2025-09-30 | $55.00K 10-Q · filed 2025-11-12 | $77.00K derived: sum of 2 quarters · filed 2026-08-13 | $2.00K 10-Q · filed 2025-11-12 | $94.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $22.00K 10-Q · filed 2026-08-13 | -$53.00K 10-Q · filed 2026-08-13 | $39.00K derived: sum of 3 quarters · filed 2026-08-13 | $89.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | -$75.00K 10-Q · filed 2026-05-13 | $17.00K derived: sum of 2 quarters · filed 2026-05-13 | $67.00K derived: sum of 3 quarters · filed 2026-05-13 | $117.00K derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $142.00K derived: sum of 2 quarters · filed 2026-03-17 | $192.00K derived: sum of 3 quarters · filed 2026-03-17 | $74.00K 10-K · filed 2026-03-17 | ||
| 2024-09-30 | $50.00K 10-Q · filed 2025-11-12 | $100.00K derived: sum of 2 quarters · filed 2025-11-12 | -$18.00K 10-Q · filed 2025-11-12 | $15.00K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $50.00K 10-Q · filed 2025-08-14 | -$68.00K 10-Q · filed 2025-08-14 | -$35.00K derived: sum of 3 quarters · filed 2025-08-14 | -$39.00K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | -$118.00K 10-Q · filed 2025-05-15 | -$85.00K derived: sum of 2 quarters · filed 2025-05-15 | -$89.00K derived: sum of 3 quarters · filed 2025-05-15 | -$119.00K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $29.00K derived: sum of 2 quarters · filed 2025-03-20 | -$1.00K derived: sum of 3 quarters · filed 2025-03-20 | $63.00K 10-K · filed 2025-03-20 | ||
| 2023-09-30 | -$4.00K 10-Q · filed 2024-11-14 | -$34.00K derived: sum of 2 quarters · filed 2024-11-14 | $30.00K 10-Q · filed 2024-11-14 | -$55.00K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$30.00K 10-Q · filed 2024-08-12 | $34.00K 10-Q · filed 2024-08-12 | -$51.00K derived: sum of 3 quarters · filed 2024-08-12 | -$61.00K derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | $64.00K 10-Q · filed 2024-05-15 | -$21.00K derived: sum of 2 quarters · filed 2024-05-15 | -$31.00K derived: sum of 3 quarters · filed 2024-05-15 | -$35.00K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | -$85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$95.00K derived: sum of 2 quarters · filed 2024-03-18 | -$99.00K derived: sum of 3 quarters · filed 2024-03-18 | -$102.00K 10-K · filed 2024-03-18 | ||
| 2022-09-30 | -$10.00K 10-Q · filed 2023-11-13 | -$14.00K derived: sum of 2 quarters · filed 2023-11-13 | -$17.00K 10-Q · filed 2023-11-13 | -$35.00K derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | -$4.00K 10-Q · filed 2023-08-08 | -$7.00K 10-Q · filed 2023-08-08 | -$25.00K derived: sum of 3 quarters · filed 2023-08-08 | -$33.00K derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | -$3.00K 10-Q · filed 2023-05-11 | -$21.00K derived: sum of 2 quarters · filed 2023-05-11 | -$29.00K derived: sum of 3 quarters · filed 2023-05-11 | -$33.00K derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$26.00K derived: sum of 2 quarters · filed 2023-03-29 | -$30.00K derived: sum of 3 quarters · filed 2023-03-29 | -$17.00K 10-K · filed 2023-03-29 | ||
| 2021-09-30 | -$8.00K 10-Q · filed 2022-11-14 | -$12.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.00K 10-Q · filed 2022-11-14 | -$26.00K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$4.00K 10-Q · filed 2022-08-11 | $9.00K 10-Q · filed 2022-08-11 | -$18.00K derived: sum of 3 quarters · filed 2022-08-11 | -$134.00K derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $13.00K 10-Q · filed 2022-05-13 | -$14.00K derived: sum of 2 quarters · filed 2022-05-13 | -$130.00K derived: sum of 3 quarters · filed 2022-05-13 | -$13.39M derived: sum of 4 quarters · filed 2022-05-13 | ||
| 2020-12-31 | -$27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$143.00K derived: sum of 2 quarters · filed 2022-03-31 | -$13.41M derived: sum of 3 quarters · filed 2022-03-31 | -$10.00K 10-K · filed 2022-03-31 | ||
| 2020-09-30 | -$116.00K 10-Q · filed 2021-11-15 | -$7.35M 10-Q · filed 2020-11-09 | -$13.38M derived: sum of 2 quarters · filed 2021-11-15 | $17.00K 10-Q · filed 2021-11-15 | -$68.39M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | -$13.26M 10-Q · filed 2020-08-10 | -$61.04M 10-Q · filed 2020-08-10 | ||||
| 2020-03-31 | -$47.77M 10-Q · filed 2020-05-06 | |||||
| 2019-09-30 | -$17.37M 10-Q · filed 2020-11-09 | -$41.30M derived: sum of 2 quarters · filed 2020-11-09 | -$59.85M 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | -$23.92M 10-Q · filed 2020-08-10 | -$42.48M 10-Q · filed 2020-08-10 | ||||
| 2019-03-31 | -$18.55M 10-Q · filed 2020-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |